Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Large Molecule Therapeutics

Characterization of SGN-CD123A, A Potent CD123-Directed Antibody–Drug Conjugate for Acute Myeloid Leukemia

Fu Li, May Kung Sutherland, Changpu Yu, Roland B. Walter, Lori Westendorf, John Valliere-Douglass, Lucy Pan, Ashley Cronkite, Django Sussman, Kerry Klussman, Michelle Ulrich, Martha E. Anderson, Ivan J. Stone, Weiping Zeng, Mechthild Jonas, Timothy S. Lewis, Maitrayee Goswami, Sa A. Wang, Peter D. Senter, Che-Leung Law, Eric J. Feldman and Dennis R. Benjamin
Fu Li
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: fli@seagen.com
May Kung Sutherland
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Changpu Yu
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland B. Walter
2Fred Hutchinson Cancer Research Center, Seattle, Washington.
3Division of Hematology and Department of Medicine, University of Washington, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lori Westendorf
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Valliere-Douglass
4Analytical Science, Seattle Genetics, Inc., Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucy Pan
4Analytical Science, Seattle Genetics, Inc., Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley Cronkite
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Django Sussman
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerry Klussman
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Ulrich
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martha E. Anderson
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivan J. Stone
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weiping Zeng
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mechthild Jonas
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy S. Lewis
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maitrayee Goswami
5Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sa A. Wang
5Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter D. Senter
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Che-Leung Law
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric J. Feldman
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis R. Benjamin
1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-17-0742 Published February 2018
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: November 2017 to January 2021

AbstractFull-text HTMLPDF
Total155147274688

Cited By

Article Information

Volume 17, Issue 2, pp. 554-564

DOI 
https://doi.org/10.1158/1535-7163.MCT-17-0742
PubMed 
29142066

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • Received August 4, 2017
  • Revision received September 19, 2017
  • Accepted November 9, 2017
  • Published first November 15, 2017.

Article Versions

  • Previous version (November 15, 2017 - 09:02).
  • Previous version (January 19, 2018 - 08:02).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2017 American Association for Cancer Research.

Author Information

  1. Fu Li1,*,
  2. May Kung Sutherland1,
  3. Changpu Yu1,
  4. Roland B. Walter2,3,
  5. Lori Westendorf1,
  6. John Valliere-Douglass4,
  7. Lucy Pan4,
  8. Ashley Cronkite1,
  9. Django Sussman1,
  10. Kerry Klussman1,
  11. Michelle Ulrich1,
  12. Martha E. Anderson1,
  13. Ivan J. Stone1,
  14. Weiping Zeng1,
  15. Mechthild Jonas1,
  16. Timothy S. Lewis1,
  17. Maitrayee Goswami5,
  18. Sa A. Wang5,
  19. Peter D. Senter1,
  20. Che-Leung Law1,
  21. Eric J. Feldman1, and
  22. Dennis R. Benjamin1
  1. 1Translational Research, Seattle Genetics, Inc. Bothell, Washington.
  2. 2Fred Hutchinson Cancer Research Center, Seattle, Washington.
  3. 3Division of Hematology and Department of Medicine, University of Washington, Seattle, Washington.
  4. 4Analytical Science, Seattle Genetics, Inc., Bothell, Washington.
  5. 5Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  1. ↵*Corresponding Author:
    Fu Li, Seattle Genetics, Inc., 21823 30th Drive South East, Bothell, WA 98021. Phone: 425-527-4626; Fax: 425-527-4609; E-mail: fli{at}seagen.com
  • Current address for C.-L. Law: Harpoon Therapeutics, South San Francisco, CA.

View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 17 (2)
February 2018
Volume 17, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody–Drug Conjugate for Acute Myeloid Leukemia
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody–Drug Conjugate for Acute Myeloid Leukemia
Fu Li, May Kung Sutherland, Changpu Yu, Roland B. Walter, Lori Westendorf, John Valliere-Douglass, Lucy Pan, Ashley Cronkite, Django Sussman, Kerry Klussman, Michelle Ulrich, Martha E. Anderson, Ivan J. Stone, Weiping Zeng, Mechthild Jonas, Timothy S. Lewis, Maitrayee Goswami, Sa A. Wang, Peter D. Senter, Che-Leung Law, Eric J. Feldman and Dennis R. Benjamin
Mol Cancer Ther February 1 2018 (17) (2) 554-564; DOI: 10.1158/1535-7163.MCT-17-0742

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody–Drug Conjugate for Acute Myeloid Leukemia
Fu Li, May Kung Sutherland, Changpu Yu, Roland B. Walter, Lori Westendorf, John Valliere-Douglass, Lucy Pan, Ashley Cronkite, Django Sussman, Kerry Klussman, Michelle Ulrich, Martha E. Anderson, Ivan J. Stone, Weiping Zeng, Mechthild Jonas, Timothy S. Lewis, Maitrayee Goswami, Sa A. Wang, Peter D. Senter, Che-Leung Law, Eric J. Feldman and Dennis R. Benjamin
Mol Cancer Ther February 1 2018 (17) (2) 554-564; DOI: 10.1158/1535-7163.MCT-17-0742
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • TriTAC Molecules Direct T Cells to Eliminate Solid Tumors
  • Potent TRAILR2-Mediated Tumor Cell Death via CDH17 Anchoring
  • Multiple Mechanisms of Action of anti-TIGIT Antagonists
Show more Large Molecule Therapeutics
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement